Antiverse

company

About

Antiverse is dedicated to engineering the future of drug development to change the course of people's lives.

  • 1 - 10

Details

Last Funding Type
Grant
Last Funding Money Raised
£20K
Industries
Artificial Intelligence,Biotechnology,Health Care,Life Science,Machine Learning
Founded date
Apr 1, 2017
Number Of Employee
1 - 10
Operating Status
Active

Antiverse is a new type of antibody discovery company accelerating drug development. Its platform exists at the intersection of structural biology, machine learning, and medicine to enable breakthroughs to happen more quickly and cost-effectively. It is dedicated to engineering the future of drug development to change the course of people's lives.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
£20K
Antiverse has raised a total of £20K in funding over 2 rounds. Their latest funding was raised on Jul 12, 2018 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jul 12, 2018 Grant £20K 1 Accelerate@Babraham Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Antiverse is funded by 1 investors. Accelerate@Babraham are the most recent investors.
Investor Name Lead Investor Funding Round
Accelerate@Babraham Yes Grant